Investor Kynam Capital Management, LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Kynam Capital Management, LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-08-14 13G VERA / Vera Therapeutics, Inc. 1,576,549 3,426,887
2025-05-15 13G/A CLDX / Celldex Therapeutics, Inc. 5,064,207 6,500,000
2025-05-15 13G VRDN / Viridian Therapeutics, Inc. 0
2025-05-15 13G STRO / Sutro Biopharma, Inc. 0
2025-03-17 13G/A TSVT / 2seventy bio, Inc. 5,953,825 0
2025-02-14 13G/A SNDX / Syndax Pharmaceuticals, Inc. 5,660,000 8,520,000
2025-02-14 13G ENGN / enGene Holdings Inc. 4,994,090
2025-02-14 13G/A CLDX / Celldex Therapeutics, Inc. 3,005,904 5,064,207
2025-02-14 13G/A DVAX / Dynavax Technologies Corporation 8,332,687 6,560,835
2024-11-14 13G/A BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock) 8,694,426 989,217
2024-11-14 13G/A COGT / Cogent Biosciences, Inc. 5,854,766 9,239,731
2024-11-14 13G DVAX / Dynavax Technologies Corporation 8,332,687
2024-11-14 13G/A VERA / Vera Therapeutics, Inc. 3,650,339 1,576,549
2024-03-08 13G/A MOR / MorphoSys AG - Depositary Receipt (Common Stock) 3,690,331 4,190,331
2024-02-14 13G/A OLMA / Olema Pharmaceuticals, Inc. 2,025,234 0
2024-02-14 13G CLDX / Celldex Therapeutics, Inc. 3,005,904
2024-02-14 13G COGT / Cogent Biosciences, Inc. 5,854,766
2024-02-14 13G SNDX / Syndax Pharmaceuticals, Inc. 5,660,000
2024-02-14 13G/A VERA / Vera Therapeutics, Inc. 1,409,098 3,650,339
2024-02-14 13G MOR / MorphoSys AG - Depositary Receipt (Common Stock) 3,690,331
2024-02-14 13G/A BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock) 8,694,426 8,694,426
2024-01-10 13G BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock) 7,391,581 8,694,426
2023-09-06 13G TSVT / 2seventy bio, Inc. 5,953,825
2023-03-22 13G/A OLMA / Olema Pharmaceuticals, Inc. 40,423,832 2,025,234
2023-02-10 13G CNCE / Concert Pharmaceuticals Inc 4,420,349 4,420,349
2023-02-10 13G CNCE / Concert Pharmaceuticals Inc 4,420,349
2023-02-10 13G VERA / Vera Therapeutics, Inc. 1,409,098
2023-02-10 13G OLMA / Olema Pharmaceuticals, Inc. 40,423,832
2023-02-10 13G BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock) 7,391,581